NK:IO
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy. The company develops both cell therapy and small molecule therapeutics primarily targeting cancer.
NK:IO
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Status:
Active
Total Funding:
0
Investors List
Parkwalk Advisors
Parkwalk Advisors investment in Seed Round - NK:IO
Future Planet Capital
Future Planet Capital investment in Seed Round - NK:IO